Citation: V. Zikan et al., Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps, CALCIF TIS, 68(6), 2001, pp. 352-357
Authors:
Cauley, JA
Norton, L
Lippman, ME
Eckert, S
Krueger, KA
Purdie, DW
Farrerons, J
Karasik, A
Mellstrom, D
Ng, KW
Stepan, JJ
Powles, TJ
Morrow, M
Costa, A
Silfen, SL
Walls, EL
Schmitt, H
Muchmore, DB
Jordan, VC
Citation: Ja. Cauley et al., Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial, BREAST CANC, 65(2), 2001, pp. 125-134
Authors:
Weichetova, M
Stepan, JJ
Michalska, D
Haas, T
Pols, HAP
Uitterlinden, AG
Citation: M. Weichetova et al., COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures, BONE, 26(3), 2000, pp. 287-290
Authors:
Halleen, JM
Karp, M
Viloma, S
Laaksonen, P
Hellman, J
Kakonen, SM
Stepan, JJ
Holmes, S
Vaananen, HK
Pettersson, K
Citation: Jm. Halleen et al., Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatasebased on characterization of six monoclonal antibodies, J BONE MIN, 14(3), 1999, pp. 464-469
Citation: Jj. Stepan et J. Vokrouhlicka, Comparison of biochemical markers of bone remodelling in the assessment ofthe effects of alendronate on bone in postmenopausal osteoporosis, CLIN CHIM A, 288(1-2), 1999, pp. 121-135
Citation: Pd. Broulik et al., Beta 2-microglobulin does not behave as a biological marker of bone remodelling in patients with primary hyperparathyroidism, CLIN CHIM A, 278(1), 1998, pp. 61-66